Anupam Rasayan Completes Acquisition of Controlling Stake in Bliss GVS Pharma
Anupam Rasayan India Limited has completed its acquisition of a controlling 50.07% stake in Bliss GVS Pharma, expanding into finished dosage pharmaceutical formulations. The deal involved acquiring over 5.3 crore shares at prices around Rs 299 to Rs 723 per share, funded through loans and investments led by Bain Capital. Bliss GVS Pharma, founded in 1984, offers more than 150 brands across various therapeutic segments and reported a turnover exceeding Rs 1,000 crore in FY2023-24. The acquisition aims to enhance Anupam Rasayan's pharmaceutical value chain presence and support long-term growth.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (62/100). Lens Score 45/100.
Outlets measured: economictimes, freepressjournal. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
freepressjournal broke this story on 29 Sept, 04:46 am. Other outlets followed.